Formulation Comprising A Mek Inhibitor - EP3702351

The patent EP3702351 was granted to Array Biopharma on Nov 22, 2023. The application was originally filed on Oct 18, 2013 under application number EP19211405A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP3702351

ARRAY BIOPHARMA
Application Number
EP19211405A
Filing Date
Oct 18, 2013
Status
Granted And Under Opposition
Oct 20, 2023
Grant Date
Nov 22, 2023
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

TER MEER STEINMEISTER & PARTNER PATENTANWALTE MBBAug 21, 2024ADMISSIBLE
STADA ARZNEIMITTELAug 2, 2024ADMISSIBLE

Patent Citations (10) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
DESCRIPTIONWO03077914
OPPOSITIONEP1797881
OPPOSITIONEP2909182
OPPOSITIONEP3702351
OPPOSITIONWO03077914
OPPOSITIONWO2012145503
OPPOSITIONWO2013033133
OPPOSITIONWO2014063024
SEARCHWO03077914
SEARCHWO2007076245

Non-Patent Literature (NPL) Citations (14) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
DESCRIPTION- ASCIERTO et al., "J. Clin. Oncol.", 2012 ASCO Annual Meeting, Abstract No. 8511, (20120000), vol. 30-
DESCRIPTION- CHEMICAL ABSTRACTS, Database accession no. 1023742-13-3-
DESCRIPTION- DHILLON et al., Oncogene, (20070000), vol. 26, pages 3279 - 3290-
DESCRIPTION- FINN et al., "J. Clin. Oncol.", 2012 Gastrointestinal Cancers Symposium, Abstract No. 220, (20120000), vol. 30, no. 4-
DESCRIPTION- FREMINMELOCHE, J. Hematol. Oncol., (20100000), vol. 3, page 8-
DESCRIPTION- HAURA et al., Clin. Cancer Res., (20100000), vol. 16, pages 2450 - 2457-
DESCRIPTION- MURUGAN et al., Cell Cycle, (20090000), vol. 8, pages 2122 - 2124-
DESCRIPTION- SASAKI et al., J. Thorac. Oncol., (20100000), vol. 5, pages 597 - 600-
OPPOSITION- Anonymous, "Passage ; Die Tablette Handbuch der Entwicklung, Herstellung und Qualitats", Anonymous, Wolfgang A. Ritschel , Annette Bauer-Brandl, Die Tablette Handbuch der Entwicklung, Herstellung und Qualitätssicherung, Edito Cantor Verlag , (20020101), pages 67 - 79, ISBN 978-3-87193-228-1, XP093209612-
OPPOSITION- J.I. Wells, M.E. Aulton, "Chapter 24: Pharmaceutical preformulation", J.I. Wells, M.E. Aulton, Michael E. Aulton, Aulton's Pharmaceutics, The Design and Manufacture of Medicines, 3rd edition, Churchill Livingstone Elsevier, (20070101), pages 336 - 361, ISBN 978-0-443-10107-6, XP009552396-
OPPOSITION- Michael E. Aulton, "Tablet Excipients", Michael E. Aulton, MICHAEL E. AULTON, Pharmaceutics: The Science of Dosage Form Design, 2nd Edition, CHURCHILL LIVINGSTONE, (20070101), pages 448 - 455 + 482, ISBN 0-443-10107-8, XP009559831-
OPPOSITION- Raymond C Rowe , Paul J Sheskey B , Marian E Quinn B, Handbook of Pharmaceutical Excipients Sixt edition, Pharmaceutical Press, (20090101), ISBN 9781582121352-
OPPOSITION- Wolfgang A. Ritschel ; Annette Bauer-Brandl, "Passage chapter 2 - 2.3", Wolfgang A. Ritschel ; Annette Bauer-Brandl, Wolfgang A. Ritschel ; Annette Bauer-Brandl, Die Tablette : Handbuch der Entwicklung, Herstellung und Qualitätssicherung, Aulendorf, DE, ECV - Editio-Cantor-Verl., (20020101), page 68, ISBN 3-87193-228-0, XP009556927-
OPPOSITION- Francesco Spagnolo, "Upcoming strategies for the treatment of metastatic melanoma", Arch Dermatol Res, (2012), vol. 304, doi:10.1007/s00403-012-1223-7, XP035032928

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents